Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Examining the Effects of Mindfulness and Similar Audio-guided Exercises.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03797599
Recruitment Status : Completed
First Posted : January 9, 2019
Last Update Posted : December 11, 2019
Sponsor:
Information provided by (Responsible Party):
Canterbury Christ Church University

Brief Summary:
This study aims to examine whether greater length of mindfulness practice results in more beneficial outcomes.

Condition or disease Intervention/treatment Phase
Mindfulness Healthy Population Behavioral: 20 minutes of mindfulness practice Behavioral: 5 minutes of mindfulness practice Other: 5 minute audio book Other: 20 minute audio book Other: 25 minute audio book Not Applicable

Detailed Description:
This study will randomise participants to one of three groups: (1) four sessions of medium length mindfulness practice (lasting 20 mins) and 5 mins of an audio book; (2) four sessions of brief mindfulness practice (lasting 5 mins) and 20 mins of an audio book; and (3) a control group who just receive 4 sessions of audio book (lasting 25 mins). In the mindfulness arms, in each session, the participants will receive the audio book prior to the mindfulness practice. Mindfulness levels, and depression, anxiety and stress will be measured by self-report at baseline, session by session, and at post-intervention.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 71 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Masking Description: Participants will be masked to the extent that they will not be told which group they have been allocated to nor the exact nature of the the three groups. However, they will be aware of the exercises they are asked to undertake.
Primary Purpose: Basic Science
Official Title: The Effects of Length of Mindfulness Practice on Mindfulness, Depression, Anxiety and Stress: A Randomised Controlled Experiment
Actual Study Start Date : March 28, 2019
Actual Primary Completion Date : December 5, 2019
Actual Study Completion Date : December 5, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anxiety

Arm Intervention/treatment
Experimental: 20 minutes of mindfulness practice
Two sessions a week for two weeks of: 5 minutes listening to audio book excerpts followed by 20 minutes of audio guided mindfulness practice. Participants will be asked not to engage in formal mindfulness practice outside of these sessions during the study.
Behavioral: 20 minutes of mindfulness practice
A 20 minute audio guided mindfulness of breathing practice per session, for four sessions.

Other: 5 minute audio book
5 minutes from an audio book by Bill Bryson ('A Short History of Nearly Everything') per session, for four sessions.

Active Comparator: 5 minutes of mindfulness practice
Two sessions a week for two weeks of: 20 minutes listening to audio book excerpts followed by 5 minutes of audio guided mindfulness practice. Participants will be asked not to engage in formal mindfulness practice outside of these sessions during the study.
Behavioral: 5 minutes of mindfulness practice
A 5 minute audio guided mindfulness of breathing practice per session, for four sessions.

Other: 20 minute audio book
20 minutes from an audio book by Bill Bryson ('A Short History of Nearly Everything'), per session, for four sessions.

Placebo Comparator: Audio book control
Two sessions a week for two weeks of: 25 minutes listening to audio book excerpts (with non mindfulness practice). Participants will be asked not to engage in formal mindfulness practice during the study.
Other: 25 minute audio book
25 minutes from an audio book by Bill Bryson ('A Short History of Nearly Everything'), per session, for four sessions.




Primary Outcome Measures :
  1. Change from baseline at post-intervention (week 3) on the Five Factor Mindfulness Questionnaire -15 item version (FFMQ-15) [ Time Frame: Post-intervention (3 weeks after baseline). ]
    The Five Factor Mindfulness Questionnaire -15 item version is a self-report measure of mindfulness, producing a total score between 15 and 75, with higher scores indicating greater levels of mindfulness. (Note that the observe subscale will be excluded from the calculation of the total score, as recommended in https://doi.org/10.1002/jclp.21865 and http://dx.doi.org/10.1037/pas0000263 producing a total score between 12 and 60).


Secondary Outcome Measures :
  1. Change from baseline at post-intervention (week 3) on the Depression, Anxiety and Stress Scale - 21 item version (DASS-21). [ Time Frame: Post-intervention (3 weeks after baseline). ]
    The Depression, Anxiety and Stress Scale - 21 is a self-report measure of depression, anxiety and stress, producing a total score between 0 and 63, with higher scores indicating greater symptomatology.


Other Outcome Measures:
  1. Sessional Five Factor Mindfulness Questionnaire -15 item version (FFMQ-15) scores. [ Time Frame: Baseline, session 2 (week 1), session 3 and 4 (week 2), and post-intervention (week 3). ]
    The FFMQ-15 (described above) will be administered at the start of the first session (baseline), immediately after sessions 2 (week 1), 3 (week 2) and 4 (week 2), and at post-intervention (week 3), to examine patterns in changes in mindfulness over the course of the study.

  2. Sessional Depression, Anxiety and Stress Scale - 21 item version (DASS-21) scores [ Time Frame: Baseline, session 2 (week 1), session 3 and 4 (week 2), and post-intervention (week 3). ]
    The DASS-21 (described above) will be administered at the start of the first session (baseline), immediately after sessions 2 (week 1), 3 (week 2) and 4 (week 2), and at post-intervention (week 3), to to examine patterns in changes over the course of the study.

  3. Session 1 Toronto Mindfulness Scale (TMS). [ Time Frame: Session 1 (week 1). ]
    The TMS is a 13-item self-report measure of state mindfulness that produces scores for curiosity and decentering. The curiosity score ranges from 0 to 24, the decentering score from 0 to 28, and the total score from 0 to 52, with higher scores indicating greater curiosity, decentering and overall state mindfulness respectively.

  4. Session 2 Toronto Mindfulness Scale (TMS). [ Time Frame: Session 2 (week 1). ]
    As described above.

  5. Session 3 Toronto Mindfulness Scale (TMS). [ Time Frame: Session 3 (week 2). ]
    As described above.

  6. Session 4 Toronto Mindfulness Scale (TMS). [ Time Frame: Session 4 (week 2). ]
    As described above.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Members of the general public, especially university students or staff.
  • Adequate understanding of spoken and written English

Exclusion Criteria:

  • Currently experiencing significant difficulties with their mental wellbeing.
  • Currently have a personal mindfulness practice.
  • Currently participating in a mindfulness-based intervention.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03797599


Locations
Layout table for location information
United Kingdom
Canterbury Christ Church University
Tunbridge Wells, Kent, United Kingdom, TN1 2YG
Sponsors and Collaborators
Canterbury Christ Church University
Investigators
Layout table for investigator information
Study Director: Fergal Jones, PhD, PsychD Canterbury Christ Church University
Study Director: James Cane, PhD Canterbury Christ Church University
Principal Investigator: Sarah Strohmaier, MSc Canterbury Christ Church University
Layout table for additonal information
Responsible Party: Canterbury Christ Church University
ClinicalTrials.gov Identifier: NCT03797599    
Other Study ID Numbers: S_Strohmaier_29-11-18
First Posted: January 9, 2019    Key Record Dates
Last Update Posted: December 11, 2019
Last Verified: September 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No